نتایج جستجو برای: cd226

تعداد نتایج: 208  

2015
Raffaele Caruso Silvia Rocchiccioli Anna Maria Gori Antonella Cecchettini Betti Giusti Guido Parodi Lorena Cozzi Rossella Marcucci Marina Parolini Ilaria Romagnuolo Lorenzo Citti Rosanna Abbate Oberdan Parodi

BACKGROUND In acute coronary syndrome (ACS), inflammation and redox response are associated with increased residual platelet reactivity (RPR) on clopidogrel therapy. We investigated whether clopidogrel interaction affects platelet function and modulates factors related to inflammation and oxidation in ACS patients differently responding to clopidogrel. MATERIAL AND METHODS Platelet aggregatio...

Journal: :Blood 2011
Michele Ardolino Alessandra Zingoni Cristina Cerboni Francesca Cecere Alessandra Soriani Maria Luisa Iannitto Angela Santoni

An important role for natural killer (NK) cells in the regulation of T-cell responses is emerging, although the receptor pairs regulating the NK-T-cell interaction have still not been identified. We found that superantigen-stimulated T cells express Nectin-2 (CD112) and poliovirus receptor (PVR; CD155), the ligands of the activating NK receptor DNAX accessory molecule-1 (DNAM-1; CD226). Interes...

2015
Zhanguang Zhang Ning Wu Yan Lu Dominique Davidson Marco Colonna André Veillette

DNAM-1 (CD226) is an activating receptor expressed on natural killer (NK) cells, CD8(+) T cells, and other immune cells. Upon recognition of its ligands, CD155 and CD112, DNAM-1 promotes NK cell-mediated elimination of transformed and virus-infected cells. It also has a key role in expansion and maintenance of virus-specific memory NK cells. Herein, the mechanism by which DNAM-1 controls NK cel...

2013
Maria I. Zervou Efsevia Myrthianou Irene Flouri Darren Plant Gregory Chlouverakis Francesc Castro-Giner Panayiota Rapsomaniki Anne Barton Dimitrios T. Boumpas Prodromos Sidiropoulos George N. Goulielmos

Treatment strategies blocking tumor necrosis factor (anti-TNF) have proven very successful in patients with rheumatoid arthritis (RA), showing beneficial effects in approximately 50-60% of the patients. However, a significant subset of patients does not respond to anti-TNF agents, for reasons that are still unknown. The aim of this study was to validate five single nucleotide polymorphisms (SNP...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید